6th Cancer Care Symposium
Friday, September 14, 2018, 5–8:30 p.m.
Embassy Suites Monterey Bay
Symposium and dinner: $50
Navigating the tsunami of new, targeted cancer treatments
The Food and Drug Administration approved 46 drugs in 2017, and cancer medications led the way, with 16 oncology and 11 hematology drugs. The volume marks a sea change from a decade ago, when perhaps only a half-dozen cancer drugs were approved each year.
While promising for patients, this wave of immunotherapies and targeted therapies presents challenges for clinicians, who must find more time to track and research them.
These novel therapies were expected to be less toxic than traditional chemotherapy, but they can have significant side effects. As their use increases, oncology nurses, as well as non-oncology nurses and doctors, need basic understanding of how the drugs work to help manage toxicities, improve patient compliance with treatment regimens, and potentially improve clinical outcomes.
Community Hospital of the Monterey Peninsula’s Comprehensive Cancer Center and the UCSF Helen Diller Family Comprehensive Cancer Center are providing a CME event to help prepare clinicians to contribute to successful management of patients on immunotherapy and targeted therapy. Faculty from UCSF and the Monterey Bay community will engage clinicians in an interactive discussion on an interdisciplinary approach to managing these patients.
5-6 p.m. Reception and exhibitor showcase
6-6:25 p.m. Dinner
6:25-6:30 p.m. Welcome
Grant Swanson, MD
Comprehensive Cancer Center
Community Hospital of the Monterey Peninsula
6:30-8:20 p.m. Navigating the tsunami of new, targeted cancer
- Interaction between cancer and immune system
- Targeted therapy
- Interactive case study
8:20-8:30 p.m. Question-and-answer session
Lissa Gray, MSN, FNP, earned her master’s degree in nursing from the University of California San Francisco. She is certified as a family nurse practitioner and an advanced oncology nurse practitioner. She cares for patients at UCSF with blood-related cancers, such as leukemia and lymphoma. Her clinical focus and research interest is cancer immunotherapy — how to harness the patient’s own immune system to fight cancer.
Denise Licini, NP, AOCNP, received her master’s degree in nursing from Rutgers University in Newark, New Jersey. After working on the East Coast, she moved to Monterey in 2012 and joined Pacific Cancer Care. She cares for chemotherapy patients in the outpatient setting and provides education and genetic counseling. She also volunteers at RotaCare clinic in Seaside, which provides free care to people in need.
The primary audience for this symposium is people directly involved in cancer treatment, including nurses, nurse practitioners, pharmacists, oncologists, radiation oncologists, surgeons, and pathologists. Primary care doctors and their office staff members will also find this program useful as they share in the care of these patients.
After completing this symposium, participants will be able to:
- Identify the principles of immunotherapy and targeted therapy
- Apply knowledge of mechanisms of action of various immunotherapy and targeted therapy agents into their management of potential side effects of these agents
- Identify challenges of immunotherapy and targeted therapy and outline strategies to overcome them
Statement of need. With the accelerating number of cancer drugs being approved, most clinicians are not able to spend time researching each in great detail. Oncology nurses, as well as non-oncology nurses and doctors, need a basic understanding of the drugs’ mechanisms of action, as well as potentially significant side effects. To improve management of patients, clinicians will engage in an interactive discussion with faculty from UCSF and the local community about interdisciplinary approaches to managing patients receiving immunotherapy and targeted therapy.
CME accreditation. Community Hospital of the Monterey Peninsula is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
CME credit designation. Community Hospital of the Monterey Peninsula designates this live activity for a maximum of X AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
Cultural and linguistic competency. Cultural and linguistic competency was incorporated into the planning of this activity in compliance with California Assembly Bill 1195.
Speaker and planning committee disclosure. Community Hospital’s Continuing Medical Education Identification and Resolution of Conflict of Interest Policy requires all individuals in a position to control the content of an educational activity to disclose financial relationships with any commercial or proprietary entity that produces healthcare-related products and/or services relevant to the content presented, planned, or developed for this activity. This includes any financial relationships within the last 12 months, as well as known financial relationships of a spouse or partner. This also includes any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. All planners and presenters have nothing to disclose. Community Hospital did not receive commercial support for this live educational activity.